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SUMMARY
In chapter 1 the background information on the problem of malaria is summarized. An 
overview is given of research on the different target antigens for malaria vaccine develop­
ment. Vaccines are being developed against antigens present on sporozoites, merozoites and 
gametocytes. The attention is focused on transmission-blocking vaccines. Antibodies recog­
nizing gametocytes or gametes block the development of the parasite inside the mosquito 
midgut after the mosquito has taken a bloodmeal on an infected individual. A transmission- 
blocking vaccine can be used alone or in a multi-target vaccine. People living in endemic 
areas that are infected repeatedly with Plasmodium falciparum or Plasmodium vivax develop 
antibodies against gametocytes that block transmission of the parasite. Target antigens presenl 
on P. falciparum gameteocytes are Pfs48/45 and Pfs230. Other targets for transmisison- 
blocking vaccines are Pfs25 and Pfs28 present on P. falciparum zygotes and ookinetes. In this 
thesis a Plasmodium berghei mouse model is presented in which gametocyte-dependenl 
transmission-blocking immunity (TBI) can be studied. This model is suitable for the study of 
the mechanisms and dynamics of TBI.
In chapter 2 the methods used and developed to study transmission and transmission- bloc­
king immunity (TBI) of P. berghei are described. Two strains of P. berghei were used: P. 
berghei ANKA (Pb ANKA) produces both asexual parasites and gametocytes while P. berghe> 
K173 (Pb K173) only produces asexual parasites. Transmission of Pb ANKA can be studies 
using 3 different methods: direct feeding, the minifeeder assay and the in vitro ookinete 
culture assay. The most direct way to study TBI is to allow mosquitoes to feed directly on 
immunized or premune mice. All the factors affecting TBI are present. The minifeeder assay 
is used to dissect the factors responsible for transmission-reducing activity. The effect on 
transmission of white blood cells, serum or antibodies added to an infectious bloodmeal 
containing Pb ANKA gametocytes can be determined. An in vitro ookinete culture test can 
also be used to dissect TBI. In addition, this test can discriminate between targets of TBI on 
gametocytes/gametes/zygotes and later developmental stages. The ookinete culture assay is 
comparatively fast (24 hours) and only small amounts of test serum are needed, however, 
agreement with the results obtained from direct feeding was observed in only 76% of the 
cases so far (see chapter 5).
Large quantities of infectious Pb ANKA gametocytes are required for the induction of a 
gametocyte-specific TBI. Previously described methods for the isolation of large quantities of 
non-activated gametocytes inside mouse erythrocytes did not meet with our requirements. A 
new method is described in chapter 3. Purified samples contained 90% gametocytes, 5% 
asexual stages and 5% cell-ghosts. Purified gametocytes were infectious to mosquitoes both 
after injection into naïve mice as well as in the minifeeder assay.
The induction of a gametocyte-specific TBI is described in chapter 4. Mice were immunized 
with Freund's adjuvant mixed with purified gametocytes of Pb ANKA (GCT-FA) or mixed 
with purified asexual parasites from Pb K173 (K173-FA). As control mice were immunized 
with saline mixed with Freund's adjuvant (saline-FA). Mice immunized with GCT-FA redu­
ced transmission significantly better than K173-FA immunized mice. TBI induced by GCT- 
FA was antibody dependent as corresponding antibody enriched preparations obtained by 
ammonium sulphate precipitation also reduced transmission when tested in a minifeeder 
assay. Serum from GCT-FA immunized mice did not recognize Pbs21 on western-immuno- 
blots and serum did not affect transmission by cultivated ookinetes. From this it was conclu-
ded that GCT-FA serum contains antibodies targeted to early stages in the mosquito vector. 
Sera from GCT-FA immunized mice recognized an antigen on western-immunoblots contai­
ning Pb ANKA gametocytes with a relative molecular weight of 60kDa. Pb60 was not presenl 
on Pb K173 western-immunoblots. The location and the relevance of Pb60 in TBI remains to 
be determined.
Chapter 5 describes the effects of GCT-FA and K173-FA immune sera on transmission of Pb 
ANKA and early gametocyte to ookinete development. Mice were immunized with GCT-FA 
or K173-FA. The TRA of GCT-FA immunized mice was significantly higher in comparison 
with the TRA of K173-FA immunized mice. Of K173-FA immunized mice 29% reduced 
transmission significantly better than saline-FA immunized mice, and this was comparable to 
the percentage (31%) observed in the experiments described in chapter 4. Pooled serum from 
GCT-FA and K173-FA immunized mice with significant TRA (respectively GCT-FA+ and 
K173-FA+) reduced transmission of Pb ANKA when tested in a minifeeder assay. Discrepan­
cy with the observation in chapter 4 that pooled serum from K173-FA immunized mice does 
not block transmission depends on dilution of TBI in the serum-pool used in chapter 4. K173- 
FA serum did not block in vitro development of ookinetes, which probably depends on a 10 
times lower number of white blood cells (WBC's) in this assay. Since WBC's have an effecl 
on transmission it was concluded that K173-FA immunized mice either reduce transmission 
aspecifically or only in the presence of WBC's. Serum from GCT-FA immunized mice 
blocked in vitro ookinete development only when added before the start or 20 minutes after 
the start of the ookinete culture indicating that antibodies present in the serum (chapter 4) 
probably blocked fertilization.
The results of the TRA determined by both the in vitro ookinete culture test and by direcl 
feeding were compared. Analysis of the data showed agreement in 76% of the cases. The 
sensitivity of the ookinete culture test was 80% while the specificity was 67% in comparison 
to direct feeding.
Persistence of TBI in the absence of parasites is described in chapter 6. Mice were immuni­
zed either with gametocytes mixed with Freund's adjuvant (GCT-FA) or mice were immuni­
zed intravenously with gametocytes without adjuvant (GCT (i.v.)). Although antibody titres in 
GCT (i.v.) immunized mice were higher than in GCT-FA immunized mice, immunization 
with GCT-FA was more effective. The use of an adjuvant affects the quantity, affinity, isotype 
and epitope specificity of antibodies and this may explain why GCT-FA immunized mice 
reduced transmission more effectively. TBI persisted in GCT-FA immunized mice for at leasl 
40 weeks but there was no clear time dependency in the changes of TBI. Of the GCT (i.v.) 
immunized mice 40% had lost TBI after a parasite free period of 17 weeks.
Chapter 7 describes transmission-reducing activity (TRA) of premune mice. The immune 
system of premune mice controls parasitaemia at a subpatent level. Premunition can be 
induced in mice using low grade infections controlled by suppressive chemotherapy in the 
drinking water. Both Pb ANKA and Pb K173 premune mice have a strong TRA, however, 
sera or IgG preparation from these mice did not affect transmission of Pb ANKA when tested 
in a minifeeder assay. Anti-gametocyte antibodies in premune sera, determined in a gametocy- 
te ELISA were approximately 20 times higher than antibody titres in GCT-FA immunized 
mice. These antibodies were apparently not involved in TRA. In addition, sera from Pb 
ANKA and Pb K173 premune mice did not recognize the gametocyte-specific antigen Pb60 
(see chapter 4). When white blood cells (WBC's) were removed from infectious blood with a 
PlasmodipurR filter before the blood was mixed with premune test serum, the transmission
increased. However, this was independent of antibodies present in the inoculum. This sugge­
sted that TRA of premune mice was non-specific, and that the gametocyte load in Pb ANKA 
premune mice was too low to induce a gametocyte-dependent transmission-blocking immuni­
ty.
In chapter 8 the results described in this thesis and the relevance of the developed model 
were discussed.
GENERAL DISCUSSION
The aim of the study was to develop gametocyte-specific transmission-blocking immunity 
(TBI) in the P. berghei mouse model. The availability of two parasite strains, one that produ­
ces gametocytes (P. berghei ANKA; Pb ANKA) and one that does not produce gametocytes 
(P. berghei K173; Pb K173) made it possible to study gametocyte-specificity of induced 
immunity as well as possible cross-reactivity with asexual stage molecules.
A new method was developed to produce and purify large numbers of non-synchronous and 
infectious gametocytes inside mouse erythrocytes (chapter 3). Morphological analysis of these 
preparations showed no contamination with activated and released gametocytes. Moreover, 
immunization with these gametocytes did not result in antibodies that blocked transmission by 
cultivated ookinetes or recognized Pbs21 (Winger et al. 1988) on western-immunoblol 
(chapter 4). Thus, batches of purified gametocytes were not contaminated with Pbs21 contai­
ning stages.
Direct feeding of mosquitoes on mice previously immunized with GCT-FA or K173-FA, 
showed that immunization with gametocytes effectively induced TBI (chapter 4, 5 & 6). TB] 
of GCT-FA immunized mice was antibody mediated because both serum and its antibody 
preparation exhibited strong TBI in a minifeeder assay (chapter 4). TBI observed by direcl 
feeding on immunized and subsequently infected mice was not dependent on immune media­
ted loss of infectiousness of the gametocytes that developed in the test infection (chapter 4). 
The in vitro gametocyte-ookinete culture assay was used to analyze the effect of immune 
serum on early ookinete development (chapter 5). The ookinete culture test can be read after 
24 hours in comparison with 10 days when direct feeding or the minifeeder assay are used. In 
addition, the test can be performed in large numbers and only small amounts of test serum are 
required. The question is whether the ookinete culture test can predict the results seen after 
feeding (chapter 5). The observed sensitivity (85%) and specificity (67%) indicate that optimi­
zation of the ookinete test is needed. The role of white blood cells must be analysed and the 
efficiency and accuracy of the counting of ookinetes after 24 hours of culture might be studied 
to improve the sensitivity of the test.
A false negative result might be obtained when TB-factors in the host are not present or 
effective in the ookinete test. For instance, the factors that cause TBI observed by direcl 
feeding in K173 premune mice.
The in vitro gametocyte-ookinete culture test showed that serum from mice GCT-FA immuni­
zed mice was targeted to molecules expressed on gametocytes and freshly released gametes 
and probably blocked fertilization of gametes (chapter 5).
TBI was studied before in animal models (Carter & Chen 1976; Gwadz 1976; Gwadz & 
Green 1978; Mendis & Targett 1979; Kaushik et al. 1982; Gwadz & Koontz 1984; Winger et 
al. 1988). In all these methods either no attention was given to activation of gametocytes, 
causing contamination with developing gametes, or mixtures of gametocytes and gametes, or 
gametes and ookinetes were used intentionally for immunization. Therefore, the working 
principle of the induced TBI was not necessarily directed against gametocytes. The mecha­
nism of TBI was studied in chickens immunized with P. gallinaceum. Anti-gamete monoclo­
nal antibodies recognizing Pgs230 caused agglutination and blocked fertilization (Rener et al. 
1980; Aikawa et al. 1981). It is assumed that antibodies recognizing Pfs48/45 also block 
fertilization (Vermeulen et al. 1985). The mechanism described in the P. berghei model is 
probably similar to those described above.
Comparative western-immunoblotting on blots containing Pb ANKA gametocytes and Pb 
K173 asexual stage parasites revealed many antibody reactions to molecules common to these 
stages. In these studies one gametocyte-specific molecule was identified at a relative molecu-
lar weight of 60kDa (Pb60) (chapter 4). K173-FA immunized mice did not react to this 
molecule. Though Pb60 was only observed after immunization with gametocytes not all Pb60 
positive sera blocked transmission. An explanation for this may be that Pb60 is an internal 
and not a surface antigen of the gametocytes. Another explanation is that western-immunoblol 
reactivity is qualitative not quantitative. When monoclonals against Pb60 become available 
surface IFA's and two-site or even competition ELISA's can give the correct answer.
The presence of Pb60, a gametocyte-specific molecule in/on P. berghei gametocytes raises the 
question whether there exists analogy to Pfs230 or Pfs48/45, target antigens of TBI and found 
on P. falciparum gametocytes. More work is needed to analyse this possibility in more detail. 
Methods that could help to answer this question comprise: immuno-precipitation of molecules 
labelled on the surface of the gametocytes, or affinity purification of antibodies that specifical­
ly bind to the surface of ammonium-chloride released gametocytes, or more comparative 
western-immunoblotting using only membrane fractions of the parasite. Development of 
monoclonal antibodies using the surface immunofluorescence for selection might be used and 
screening by molecular biological methods for homologies in the genomes of P. falciparum 
and P. berghei might be helpful, the latter being outside the scope of this thesis. Attempts 
were made to apply these methods in pilot experiments and so far without success. There was, 
however, not enough priority for these experiments to conclude that they are not suitable for 
the detection of gametocyte surface molecule(s) that are target of antibody mediated TBI or to 
say that such molecules are not present.
Antibodies induced by the GCT-FA and K173-FA immunizations exhibited extensive cross­
reactivity between the gametocytes and asexual parasites. The antibodies produced by these 
immunizations exhibited high titres in (suspension) IFA (SIFA) and ELISA's (chapter 4). 
Cross-reactivity in the gametocyte-based ELISA's can be explained by the fact that many 
common, house-hold antigens can be expected which may obscure reactivity against a few 
stage specific antigens. Cross-reactivity in the SIFA indicates that there are common surface 
molecules on asexual stages and gametocytes.
These observations are not surprising because Pb K173 is originated from Pb ANKA. Pb 
K173 had lost the capacity to produce gametocytes in the course of continuous passage by 
asexual stage parasites through weekly sub-inoculation of infected blood in new animals. 
Without passages through the mosquito differentiation of gametocytes disappears (Birago et 
al. 1982; Casaglia et al. 1985; Janse et al. 1993; Janse et al. 1994). An important question is 
at what level of the gametocyte differentiation this development is blocked. Is there a master 
gene that triggers gametocyte development that has been lost from the genome or is there a 
functional defect in the course of the 2 day maturation process. Chromosomal analysis has 
shown that the genome of Pb K173 is greatly reduced in comparison to the Pb ANKA strain 
(personal communication Dr. C. Janse, Department of Parasitology, Leiden, The Netherlands) 
and in bloodsmears of Pb K173 infected mice no morphologically recognizable gametocyte 
differentiation stages can be discerned. However, this point can not be solved completely until 
the genes involved in gametocytogenesis are identified.
This raised the question whether antibody reactivity against common surface molecules of Pb 
K173 and Pb ANKA have transmission-blocking properties.
Indeed, one third of the K173-FA immunized mice also reduced or blocked transmission 
(chapter 4 & 5). The mechanism of this TBI was unclear. Was TBI antibody based? Did the 
Pb K173 strain contain early gametocyte stages that were able to induce TBI?
Pooled serum and its antibody preparation from K173-FA immunized mice did not exhibil 
TBI (chapter 4), but transmission-reducing activity was observed in the minifeeder assay 
when serum was added that was selectively pooled from mice with a mean TBI of 98%, in the 
direct feeding assay (chapter 5). This left open the possibility that immunization with Pb K173
parasites could result in antibodies that block transmission. However, when these sera were 
tested on the development of gametocytes to ookinetes in the in vitro ookinete culture assay, 
only serum from GCT-FA immunized and not from K173-FA immunized mice blocked this 
differentiation (chapter 5).
Why did sera from K173-FA immunized mice block transmission in the minifeeder assay and 
not in the ookinete assay? An important difference between the minifeeder assay and the 
ookinete assay is the concentration of white blood cells being tenfold lower in the ookinete 
development assay. It was described before that white blood cells can phagocytose parasitized 
erythrocytes (Sinden & Smalley 1976) or have strong effects on transmission (Naotunne et al. 
1993; Ranawaka et al. 1994). White blood cells present in the mosquito feed reduced trans­
mission (chapter 5). Possibly, sera from K173-FA immunized mice have opsonizing antibo­
dies that cross-react with common, house-hold molecules on the surface of gametocytes which 
are phagocytosed by the white blood cells.
An additional observation was made during these studies with respect to immunization 
against asexual stage parasites. Repeated immunization with Pb K173 parasites mixed with 
Freund's adjuvant, did not induce blockade of parasite proliferation. This indicates the diffi­
culty to immunize against the asexual stages, particularly when it is considered that parallel 
immunizations with gametocytes effectively induced TBI.
TBI could also be induced by immunization (i.v.) with gametocytes in the absence of Freund's 
adjuvant (chapter 6). The remarkable point is that higher ELISA antibody titres were obtained 
after immunization with gametocytes only, but these antibodies blocked transmission less 
efficiently than those induced after immunization with GCT-FA. This difference is probably 
due to the use of the adjuvant. Freund's adjuvant has a strong effect on induction of immunity 
(Butcher 1989). The subcutaneous mixture of adjuvant and antigen works as a depot releasing 
the antigen slowly. The adjuvant induces a protracted strong inflammatory response, which 
releases cytokines and other immuno-modulators together with the antigen. This combination 
of prolonged release of antigen and immuno-modulators determines the quality of the immune 
response e.g. epitope specificity, isotype specificity, affinity and the amount of antibody 
produced (Hadjipetrou-Kourounakis & Möller 1984; Kenney et al. 1989; Hagen et al. 1993; 
Roeffen et al. 1995). It is a well established problem in vaccine research that protection 
induced by antigen mixed with Freund's adjuvant can not be replaced by immunization with 
antigen alone or in combination with an adjuvant that is acceptable in humans. Fortunately, 
TBI can be induced by immunization with gametocytes alone, though not yet as efficient as 
mixed with adjuvant.
An important objective of these studies was to determine the duration of TBI in the absence of 
antigen. This analysis was made in mice immunized with gametocytes mixed with Freund's 
adjuvant or with gametocytes alone (chapter 6). GCT-FA not only were more effective in the 
induction of TBI (see above), but established immunity persisted for a longer period of time 
than in mice with TBI induced by gametocytes only. As already discussed above, the mos1 
likely explanation is that administration of Freund’s adjuvant induces a continuous inflamma­
tory response releasing all kinds of cytokines and other immuno-modulators, that in combina­
tion with slow release of antigen from the depot keeps immune reactivity at level. Experi­
ments need to be performed with other adjuvant to show whether an equal effectiveness on 
induction and maintenance of TBI can be obtained. For the analysis of the role of isotype, 
affinity and concentration of specific antibody in TBI the target molecule(s) of TBI must be 
known and available for serological analysis.
People with premunition are protected against clinical infections, but are carrier of the parasite
over long periods of time (Sergent 1963). A proportion of these surviving parasites will 
differentiate into gametocytes and the question is whether the antigen load that becomes 
available in this way is high enough to induce and/or maintain immunity. TBI was studied in 
mice with premunition against P. berghei parasites (Eling 1978; Eling 1980; Eling et al. 1991; 
Celluzzi 1994; Celluzzi et al. 1995).
The results in chapter 7 showed that both Pb ANKA and Pb K173 immunized mice with 
premunition had strong TBI. The mean TBI in Pb K173 mice with premunition was even 
stronger than that observed in mice immunized with gametocytes mixed with Freund's adju­
vant (chapter 4 & 5). However, no TBI was observed when the sera of the Pb K173 and Pb 
ANKA immune mice with premunition were tested in the minifeeder assay. The gametocyte- 
based ELISA showed high antibody titres in both the Pb K173 and the Pb ANKA premune 
serum. These titres were even 20-30 times higher than those observed in mice immunized 
with antigen and Freund's adjuvant (chapter 4). Continuous stimulation with parasite antigen 
apparently stimulates antibody reactivity efficiently. In addition, these results again show that 
there is extensive cross-reactivity between Pb ANKA gametocytes and Pb K173 asexual 
stages and that ELISA's cannot discriminate gametocyte-specific reactivity. Incubation of the 
sera from Pb K173 and Pb ANKA immune mice with premunition on western-immunoblots 
of gametocytes did not show reactivity with Pb60. Thus, despite high antibody titres in these 
sera, no reactivity with a gametocyte-specific antigen and no TB-activity were observed. The 
most likely explanation is that the chemotherapeutically controlled Pb ANKA infection for the 
induction of protection and premunition does not provide exposure to sufficient numbers of 
gametocytes to induce gametocyte-specific responses and TBI. The question whether establis­
hed TBI will be boosted by premunition could not be answered in this way. Probably inducti­
on of TBI by immunization with gametocytes followed by induction of premunition and 
detection of persistence of TBI in the presence and absence (chemotherapy) of parasites could 
solve this question.
Mice with premunition for Pb K173 parasites also block transmission by direct feeding, but 
not in the minifeeder assay. Although white blood cells affect transmission this effect was 
independent of the presence of specific antibody. There still is the possibility that white blood 
cells in mice with premunition have elevated expression of Fc-receptors and are more effecti­
ve in antibody-mediated phagocytosis of opsonized gametes than the white blood cells in the 
blood of the infected donor mice used as a source of gametocytes in the minifeeder assay. 
Another possibility that could explain the strong TBI in mice with premunition is that such 
mice have a continuously activated immune system that releases cytokines and other inflam­
matory mediators. These substances could affect the infectiousness of injected gametocytes 
within the 4 hours that gametocytes are exposed to these substances before mosquitoes take 
their bloodmeal. Observations that could support this possibility were described in relation to 
transmission of P. vivax (Naotunne et al. 1993). The P. berghei mouse model is suitable for 
the study of these phenomena.
We showed that it is possible to induce gametocyte-specific TBI and to study development 
and persistence of TBI in the P. berghei mouse model. The model shows that TBI is the result 
of co-operation of a number of factors. Antibodies can directly block transmission and/or 
transmission can be affected by antibody in collaboration with white blood cells. In addition, 
unspecific factors can strongly suppress transmission by direct feeding. These factors are not 
or not all represented in the serum of the mice with premunition that are tested in vitro. The 
deleterious effect of cytokines and/or other inflammatory mediators on the infectiousness of 
gametocytes is an important point in relation to transmission under field condition and could 
be the subject of future studies.
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